The current influenza strain antigen for the 2019-2020 vaccine season produced by FSUE SPbSRIVS FMBA of Russia promptly for the WHO system (GISRS) was used by the key laboratory (NIBSC) for manufacturing the standard antigen and received catalog number 19/154. This indicates a high level of quality of SPbSRIVS products that meet not only the
Tagged under: , ,
Pharmaniaga, the leading Malaysian company in the area of pharmaceutical drug supplies, is interested in adjusting the supplies of Flu-M, a new influenza vaccine produced by SPbSRIVS FMBA of Russia, in Malaysia. The Pharmaniaga official delegation headed by Shamsinar Hardzhy Shaary, the Technical Director, visited the SPbSRIVS production site on July 4–5 this year. In
Tagged under: